Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Concord Medical CoROCO:6518 -0.65%71 FCF Yield % is 12.04 as of Jul. 30, 2026, which is 46% above its 10-year median of 8.25. GuruFocus rates ROCO:6518 with a GF Score™ of 71/100 and a GF Value™ of NT$29.15 (Fairly Valued). The stock has 3 warning signs investors should review. Among 852 Medical Devices & Instruments companies, Concord Medical Co ranks better than 95.42% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Concord Medical Co's FCF Yield % or its related term are showing as below:
ROCO:6518'
s FCF Yield % Range Over the Past 10 Years
Min: -5.26 Med: 8.25 Max: 25.91
Current: 12.04
During the past 13 years, the highest FCF Yield % of Concord Medical Co was 25.91%. The lowest was -5.26%. And the median was 8.25%.
ROCO:6518's FCF Yield % is ranked better than 95.42% of 852
companies
in the Medical Devices & Instruments industry
Industry Median: -0.405
vs ROCO:6518: 12.04
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Concord Medical Co FCF Yield % Related Terms
Concord Medical Co FCF Yield % Historical Data
* Premium members only.
The historical data trend for Concord Medical Co's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6518 vs ISRG, BDX, MDLN: FCF Yield % Comparison
For the Medical Instruments & Supplies subindustry, Concord Medical Co's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Concord Medical Co FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Concord Medical Co's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Concord Medical Co's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Concord Medical Co (ROCO:6518) has a FCF Yield % of 12.04 as of Jul. 30, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Concord Medical Co and its competitors. This is 46% above median its historical median of 8.25. According to the industry distribution chart, Concord Medical Co ranks #39 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 4.6%.
Is Concord Medical Co's FCF Yield % too high?
Concord Medical Co's current FCF Yield % of 12.04 is 46% above median its 10-year median of 8.25. Based on the distribution chart, Concord Medical Co ranks #39 out of 852 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Concord Medical Co has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Concord Medical Co's FCF Yield % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Concord Medical Co ranks #39 out of 852 companies for FCF Yield %. This places Concord Medical Co in the top 5% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Concord Medical Co and its competitors. Concord Medical Co's current FCF Yield % is 12.04, which is 46% above median its own 10-year median of 8.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Concord Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Concord Medical Co (ROCO:6518) is currently considered Fairly Valued. The stock's GF Value™ is NT$29.15, compared to a current price of NT$30.40 — trading 4.3% above its estimated fair value. The current FCF Yield % is 12.04, which is 46% above median its 10-year median of 8.25. Concord Medical Co's overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Concord Medical Co (ROCO:6518), the current FCF Yield % is 12.04 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Concord Medical Co (ROCO:6518) Overvalued in 2026?
Based on GuruFocus' analysis, Concord Medical Co stock appears to be overvalued.
The current stock price of NT$30.40 is trading 4.3% above its estimated GF Value™ of NT$29.15.
GuruFocus considers Concord Medical Co to be Fairly Valued.
Key valuation signals for ROCO:6518:
FCF Yield %: 12.04 (46% above median its 10-year median of 8.25)
GF Value™: NT$29.15 vs. price of NT$30.40 (4.3% above fair value)
No single metric tells the full story. See the ROCO:6518 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Concord Medical Co Ltd is a Taiwan based company involved in providing hospital management support services including medical equipment leasing, pharmaceuticals, and medical consumables integrated supply. . The company's main business items are medical equipment, pharmaceuticals Product trading business, leasing business and management consulting services.
71GF Score
Get the complete analysis for ROCO:6518
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6518 has been successfully added to your 
